This study, called IMPACT, is looking at a mobile app called "Moodivate" to help cancer survivors who are experiencing depression. Moodivate helps you track your daily activities and mood, and suggests new activities to improve your mood. You might be a good fit for this study if you are over 18, have cancer that is likely incurable, and have symptoms of depression. You also need to own a smartphone and be willing to use a mobile app. The study will compare people who use Moodivate to those who receive educational materials about mood management. The main goal is to see if Moodivate can reduce depression symptoms after 12 weeks. The study is currently unclear on its status and plans to enroll 279 participants.

Study design

This study will randomly assign participants to either use the Moodivate app or receive educational materials. About two-thirds of participants will use the app, and one-third will receive educational materials.

What's involved

You will complete electronic questionnaires weekly for 8 weeks, with a final follow-up questionnaire at 12 weeks. If assigned to the app group, you will use the Moodivate app during this time.

Compensation

Not stated in the trial record.

Follow-up

You will have a final follow-up questionnaire at 12 weeks after joining the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.